ANDREA CHERRY: Open Payments
NPI 1881277184 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 15 payments from 10 companies in 2025. Trend: 2023 $1,088 · 2024 $788 · 2025 $470
Food & beverage: $371Education: $99
| Company | Payments | Amount |
|---|---|---|
| SOBI, INC | 2 | $114 |
| Pharmacosmos Therapeutics Inc. | 3 | $95 |
| Boston Scientific Corporation | 1 | $77 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $48 |
| Genentech USA, Inc. | 2 | $43 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| Acrotech Biopharma Inc. | 1 | $16 |
Products named: MONOFERRIC, General - Pain Management, ZYNLONTA, Phesgo, KEYTRUDA, OJJAARA, Padcev, VENCLEXTA.
Industry payments across OK — which companies pay providers there.
